ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

A RANDOMIZED CONTROL TRIAL TO DETERMINE THE ORALLY TAKEN VITAMIN-D GLYCATED HEMOGLOBIN AMONG PATIENTS OF T2DM

Dr Aqsa Shaheen, Dr Fatima Khawer, Dr Sana Ijaz

Objective: The main objective of the study was to determine the glycemic check of patients with type 2 diabetes by lessening glycated haemoglobin. It can be achieved by determining the efficiency of oral vitamin D. Methods: The experimental study was carried out on an arbitrary basis at Sir Ganga Ram Hospital, Lahore from March 2017 to September 2018. It included patients suffering from type 2 diabetes mellitus. The average age of the patients included in the study ranges from 40 to 70. They were irregularly classified into two groups. Only metformin was given to patients included in group b. While the patients of group A were given the metformin as well as vitamin D. After three months the blood specimens of both groups were collected and analyzed to identify the variations during this period. For the measurement of data SPSS was used. Results: Total of 140 persons were added in the study. These were classified into two groups on a random basis with 70 cases in every group. The average age of group-A patients were (54.40 ± 8.55). On the other hand, the average age for group-B was (58.40 ± 7.98). At the start of the study, no notable variation was identified levels of glycated haemoglobin. However, when this level was observed after 3 months of cure, a notable variation was examined. Conclusion: The level of glycated haemoglobin in patients of diabetes can be reduced notably by the addition of vitamin D. Keywords: Vitamin D, HbA1c, Diabetes Mellitus, Type 2 and Supplementation

FULL TEXT